Lymphocyte Depleted Hodgkin Lymphoma, Spleen (C81.37)

Name of the Condition

• Common Name: Lymphocyte Depleted Hodgkin Lymphoma, Spleen
• Medical Terms: LD Hodgkin Lymphoma, Lymphocyte-Depleted Hodgkin Disease (spleen)

Summary

Lymphocyte depleted Hodgkin lymphoma (LD Hodgkin lymphoma) is a rare and aggressive subtype of Hodgkin lymphoma. It is characterized by a scarcity of lymphocytes and a predominance of Reed-Sternberg cells in affected lymph nodes or tissues. This subtype often presents at an advanced stage and may involve extranodal sites, such as the liver or bone marrow. LD Hodgkin lymphoma is associated with a poorer prognosis compared to other Hodgkin lymphoma subtypes, though treatment advances have improved outcomes.

Causes

The exact cause of lymphocyte depleted Hodgkin lymphoma is not fully understood. It is thought to result from a combination of genetic mutations and environmental factors. Unlike other Hodgkin lymphoma subtypes, Epstein-Barr virus (EBV) is frequently associated with LD Hodgkin lymphoma, suggesting a potential viral role in its development. Genetic abnormalities and immune system dysregulation may also contribute.

Risk Factors

• Age: Most commonly diagnosed in adults, particularly those over 50.
• Immune Status: Weakened immunity (e.g., from HIV/AIDS or immunosuppressive therapy) increases risk.
• Epstein-Barr Virus: Prior infection is strongly associated with this subtype.

Symptoms

Symptoms may include unexplained weight loss, fever, night sweats, fatigue, and enlarged lymph nodes. Splenic involvement can cause abdominal pain or discomfort. Advanced disease may present with systemic symptoms or organ dysfunction.

Diagnosis

Diagnosis involves a combination of imaging (e.g., CT or PET scans) to assess disease extent, biopsy of affected tissue (including the spleen if involved), and histopathological examination to confirm Reed-Sternberg cells and lymphocyte depletion. Staging helps determine disease progression.

Treatment Options

Treatment typically includes chemotherapy, often with regimens like ABVD or more intensive options for advanced disease. Radiation therapy may be used for localized involvement. Stem cell transplantation is considered for relapsed or refractory cases. Treatment plans are tailored to disease stage and patient health.

Prognosis and Follow-Up

Prognosis is generally poorer than other Hodgkin lymphoma subtypes due to aggressive behavior and late presentation. However, modern therapies have improved survival rates. Regular follow-up with imaging and clinical assessments is essential to monitor for recurrence or complications.

Complications

Complications may include treatment-related toxicities (e.g., infection, organ damage), disease progression, or transformation to more aggressive lymphomas. Long-term survivors may face secondary malignancies or chronic health issues.

Lifestyle & Prevention

No specific preventive measures exist, but maintaining a healthy immune system and avoiding known risk factors (e.g., immunosuppression) may reduce risk. Supportive care, including nutrition and stress management, can aid recovery.

When to Seek Professional Help

Seek medical attention for persistent symptoms like unexplained weight loss, fever, or enlarged lymph nodes. Prompt evaluation is critical for early diagnosis and treatment, especially if symptoms worsen or new signs (e.g., abdominal pain) appear.

Tips for Medical Coders

Use C81.37 for lymphocyte depleted Hodgkin lymphoma with spleen involvement. Document the site (spleen) clearly to support code assignment. Ensure histopathological confirmation and staging details are available for accurate coding and reporting.